Articles | Open Access | https://doi.org/10.55640/

MANAGEMENT OF PATIENTS WITH ANAEMIA IN CHRONIC CARDIORENAL SYNDROME

Dilafruz Abdikhalimovna Amerova,Komilakhon Nuriddinovna Fatullaeva , Samarkand State Medical University

Abstract

Anaemia is a common and clinically significant complication in patients with chronic cardiorenal syndrome, negatively affecting functional capacity, quality of life, and overall prognosis. This study aimed to evaluate the effectiveness of oral versus intravenous iron therapy, each in combination with erythropoiesis-stimulating agents (ESAs), in the outpatient management of anaemia in patients with coexisting chronic kidney disease and chronic heart failure. A total of 80 patients were enrolled and divided into two equal groups: one received oral iron with ESAs, while the other was treated with intravenous iron and ESAs. Over a 16-week follow-up period, the group receiving intravenous iron demonstrated significantly greater improvements in haemoglobin levels, functional status (NYHA class), iron indices (ferritin, TSAT), and treatment satisfaction. They also required fewer ESA dose adjustments and had a lower incidence of anaemia-related hospitalisations. These findings support the superiority of intravenous iron supplementation in anaemia correction among patients with chronic cardiorenal syndrome, particularly in the presence of inflammation or poor gastrointestinal absorption.

Keywords

Anaemia, chronic kidney disease, chronic heart failure, cardiorenal syndrome, intravenous iron, oral iron, erythropoiesis-stimulating agents, haemoglobin, outpatient management.

References

Macdougall, I. C., & Roger, S. D. (2020). New developments in the management of anaemia in chronic kidney disease and cardiorenal syndrome. Nephrology Dialysis Transplantation, 35(1), 113–121. https://doi.org/10.1093/ndt/gfz121

Ponikowski, P., Voors, A. A., Anker, S. D., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37(27), 2129–2200. https://doi.org/10.1093/eurheartj/ehw128

KDIGO. (2012). Clinical practice guideline for anaemia in chronic kidney disease. Kidney International Supplements, 2(4), 279–335. https://doi.org/10.1038/kisup.2012.37

Silverberg, D. S., Wexler, D., Blum, M., & Iaina, A. (2014). Anaemia in chronic heart failure: Pathophysiology, impact, and treatment. Cardiology, 129(1), 4–12. https://doi.org/10.1159/000362125

Fishbane, S., & Pollack, S. (2020). Intravenous iron therapy for anaemia in chronic kidney disease: A review of clinical evidence. American Journal of Kidney Diseases, 75(5), 691–702. https://doi.org/10.1053/j.ajkd.2019.09.010

Locatelli, F., Bárány, P., Covic, A., et al. (2013). Kidney Disease: Improving Global Outcomes (KDIGO) guidelines on anaemia management: New pathways for treatment. Nephrology Dialysis Transplantation, 28(6), 1340–1349. https://doi.org/10.1093/ndt/gft032

Fatullaeva, K. N., & Amerova, D. A. (2024). Cardiorenal sindrom fonida rivojlangan kamqonlikni ambulator sharoitda davolashning zamonaviy yondashuvlari. Tibbiyot va Ilmiy Tadqiqotlar Jurnali, 3(1), 67–73.

Gazkhanovna, M. A., Makhmatovich, A. K., & Utkirovich, D. U. (2022). Clinical efficacy of extracorporeal and intravascular hemocorrection methods in psoriasis. ACADEMICIA: An International Multidisciplinary Research Journal, 12(2), 313-318.

Мадашева, А. Г. (2022). Коррекция диффузной алопеции при железодефицитной анемии. Science and Education, 3(12), 231-236.

Мадашева, А. Г., & Жураева, М. З. (2019). Биохимические показатели и комплексное лечение больных псориазом с лечебным плазмаферезом. Достижения науки и образования, (10 (51)), 78-82.

Ruziboeva, O. N., Abdiev, K. M., Madasheva, A. G., & Mamatkulova, F. K. (2021). Modern Methods Of Treatment Of Hemostasis Disorders In Patients With Rheumatoid Arthritis. Ученый XXI века, 8.

Мадашева, А. Г., Дадажанов, У. Д., Абдиев, К. М., Маматкулова, Ф. Х., & Махмудова, А. Д. (2019). Динамика электронейромиографических показателей и эффективность электрической стимуляции мышц у больных гемофилией с мышечными атрофиями. Достижения науки и образования, (10 (51)), 26-30.

Мадашева, А. Г. (2022). Клинико-неврологические изменения у больных гемофилией с мышечными патологиями. Science and Education, 3(12), 175-181.

Madasheva, A. G., Yusupova, D. M., & Abdullaeva, A. A. EARLY DIAGNOSIS OF HEMOPHILIA A IN A FAMILY POLYCLINIC AND THE ORGANIZATION OF MEDICAL CARE. УЧЕНЫЙ XXI ВЕКА, 37.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

MANAGEMENT OF PATIENTS WITH ANAEMIA IN CHRONIC CARDIORENAL SYNDROME. (2025). International Journal of Medical Sciences, 5(05), 276-281. https://doi.org/10.55640/